Raymond James & Associates’s Oak Street Health, Inc. OSH Stock Holding History

Raymond James & Associates’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-210,690	Closed	-$8.15M	–	4033
2023 Q1	$8.15M	Buy	210,690 +91,639	+77%	+$2.96M	0.01%	1150
2022 Q4	$2.56M	Buy	119,051 +3,592	+3%	+$75.1K	﹤0.01%	1839
2022 Q3	$2.83M	Buy	+115,459	New	+$3.05M	﹤0.01%	1751

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Raymond James & Associates's OSH Position: Q2 2023 in Review

Raymond James & Associates sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 210,690 shares — an estimated $8.15M sold.

Raymond James & Associates first reported a position in OSH in Q3 2022 and held it in 3 quarters. The position peaked at $8.15M in Q1 2023. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Raymond James & Associates reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Raymond James & Associates sold 210,690 Oak Street Health, Inc. shares in Q2 2023, an estimated $8.15M.
Raymond James & Associates first reported a position in Oak Street Health, Inc. in Q3 2022 and held it in 3 quarters.
Raymond James & Associates's Oak Street Health, Inc. position peaked at $8.15M in Q1 2023.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.